🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a study of HB-202/HB-201 alternating 2-vector therapy with pembroli...
Status
Withdrawn
Location
Multiple Locations
Start Date
2024-12
Trial ID
NCT06513884
Treatments Being Tested
The study is studying the joint contribution and interactions of germline v...
Status
Active Not Recruiting
Location
Hospital das Clínicas da Faculdade de Medicina de Ribeirao Preto - USP
Start Date
2022-01-18
Trial ID
NCT05215470
Treatments Being Tested
Substudy 03A is part of a larger research study that is testing experimenta...
Status
Active Not Recruiting
Location
University of California at San Francisco ( Site 1008)
Start Date
2020-12-16
Trial ID
NCT04626479
Substudy 03B is part of a larger research study that is testing experimenta...
Status
Active Not Recruiting
Location
University of California at San Francisco ( Site 3008)
Start Date
2020-12-17
Trial ID
NCT04626518
Treatments Being Tested
This is a single arm, nonrandomized, single center clinical study to invest...
Status
Unknown
Location
Hai-Tao Zhao
Start Date
2021-10-01
Trial ID
NCT05048017
Treatments Being Tested
Primary Objectives: 1. To determine the maximum tolerated dose (MTD) or ma...
Status
Terminated
Location
UC San Diego Moores Cancer Center
Start Date
2017-03-27
Trial ID
NCT03059147
The purpose of this study is to establish a prospective, single-center plat...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center Shanghai, China, 200032
Start Date
2022-11-01
Trial ID
NCT05582499
Treatments Being Tested
Objective to compare the efficacy and safety of TQB2450 injection combined ...
Status
Recruiting
Location
The Central People's Hospital of Huizhou
Start Date
2023-04-12
Trial ID
NCT06141226
Treatments Being Tested
Primary Objectives: Phase 1 -To characterize the safety and tolerability ...
Status
Terminated
Location
Investigational Site Number :2500005
Start Date
2018-12-11
Trial ID
NCT03769181
Treatments Being Tested
This is a randomized trial evaluating the results of using of PD-1 and PD-L...
Status
Recruiting
Location
N.N. Alexandrov National Caner Centre
Start Date
2025-07-01
Trial ID
NCT07472153
Treatments Being Tested